US Drug Recall Register
Class II · Moderate risk Ongoing Initiated Apr 20, 2026 (5 months ago)

NAPROXEN ORAL SUSPENSION, USP, 125 mg/5mL, Rx only, 16fl oz (473 mL) bottles, Distributed…

Class II — Moderate risk. May cause temporary or reversible harm; serious harm unlikely.

Why it was recalled

Chemical contamination; presence of lead and lithium above specification

What was recalled

NAPROXEN ORAL SUSPENSION, USP, 125 mg/5mL, Rx only, 16fl oz (473 mL) bottles, Distributed by: Acella Pharmaceuticals, LLC, Alpharetta, GA 30005, Made in Canada NDC 42192-619-16

Recalling firm
Acella Pharmaceuticals, LLC
NDC code
42192-619-16
Origin
GA, United States
Initiated by
Voluntary: Firm initiated
FDA recall number
D-0523-2026

What should you do? A recall doesn't always mean your specific bottle is affected - it often applies to certain lots only. Check the lot number on your package against the FDA notice, and talk to your pharmacist before stopping any medication.

Other Alpha recalls

See all